Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
5.11
-0.14 (-2.67%)
Aug 25, 2026, 1:37 PM EDT - Market open
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.82 billion as of August 25, 2026. Its market cap has decreased by -31.05% in one year.
Market Cap
1.82B
Enterprise Value
3.13B
1-Year Change
-31.05%
Ranking
Category
Stock Price
$5.11
ChartMarket Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.82B, an increase of 498.59%. That is a compound annual growth rate of 36.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 1.82B | 13.58% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bausch Health Companies | 2.45B |
| BioCryst Pharmaceuticals | 2.44B |
| HUTCHMED (China) | 2.18B |
| Trulieve Cannabis | 2.08B |
| Perrigo Company | 1.96B |
| Eton Pharmaceuticals | 1.85B |
| ANI Pharmaceuticals | 1.61B |
| Xeris Biopharma Holdings | 1.56B |